Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimal design for inference on the threshold of a biomarker.

Statistical methods in medical research·2024
Same author

Simulated annealing for balancing covariates.

Statistics in medicine·2023
Same author

Design considerations for two-stage enrichment clinical trials.

Biometrics·2022
Same author

Optimal and ethical designs for hypothesis testing in multi-arm exponential trials.

Statistics in medicine·2021
Same author

Compound optimal allocations for survival clinical trials.

Biometrical journal. Biometrische Zeitschrift·2020
Same author

Optimal designs for testing hypothesis in multiarm clinical trials.

Statistical methods in medical research·2018

Related Experiment Video

Updated: May 16, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

Biomarker-driven optimal designs for patient enrollment restriction.

Alessandro Baldi Antognini1, Sara Cecconi1, Rosamarie Frieri1

  • 1Department of Statistical Sciences, University of Bologna, Bologna, Italy.

Statistical Methods in Medical Research
|April 1, 2025
PubMed
Summary

This study introduces a new method for finding the best cutoff for continuous biomarkers in personalized medicine trials. The approach optimizes treatment assignment to improve patient subgroup identification and avoid ethical issues with median-based cutoffs.

Keywords:
binary responsescontinuous biomarkercovariate-adjusted response-adaptive randomizationpersonalized medicinethreshold identification

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Related Experiment Videos

Last Updated: May 16, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Personalized Medicine

Background:

  • Personalized medicine utilizes patient-specific characteristics (biomarkers) for tailored treatments.
  • Continuous biomarkers present challenges in defining patient subgroups compared to binary ones.
  • Current methods often categorize continuous biomarkers using data-driven quantiles, potentially leading to suboptimal treatment allocation.

Purpose of the Study:

  • To propose a method for determining the optimal cutoff of a continuous predictive biomarker in binary response trials.
  • To develop an optimal design for estimating this cutoff, addressing challenges with unattainable constraints.
  • To introduce a novel response-adaptive randomization technique for practical implementation.

Main Methods:

  • Derivation of an optimal design for estimating the biomarker cutoff based on relative risk.
  • Introduction of a covariate-adjusted response-adaptive randomization to minimize allocation distance to the optimum.
  • Extensive simulation studies to evaluate the proposed method's performance.

Main Results:

  • The proposed method effectively estimates the optimal biomarker cutoff.
  • The covariate-adjusted response-adaptive randomization demonstrates good estimation efficiency and variance reduction.
  • Simulations confirm the approach's performance in identifying sensitive and insensitive patient subpopulations.

Conclusions:

  • The developed method provides an optimal strategy for utilizing continuous predictive biomarkers in clinical trials.
  • The novel randomization technique ensures practical and efficient implementation.
  • Findings highlight the ethical considerations and potential drawbacks of using data-dependent medians for subpopulation identification.